Many of our clients are innovator companies developing novel treatments that are often complex and extremely high value. As a result, they face similar supply chain challenges in preparing for commercialization. Often, these specialty products are also orphan and rare disease treatments, as well as extremely low volume. The supply chains for these emerging [...]
About Arnold MaltzThis author has not yet filled in any details.
So far Arnold Maltz has created 1 blog entries.